Merck & Co.’s Winrevair Growing Into The Revenue Driver Needed Post-Keytruda LOE

Gardasil Remains A Drag Due To China Weakness

 
• By Mandy Jackson
  
CEO Robert Davis sees plenty of blue sky for Merck & Co.'s future sales growth (Shutterstock)

More from Earnings

More from Business